303 related articles for article (PubMed ID: 12015517)
21. [Ciprofloxacin/metronidazole vs. cefoxitin/doxycycline: comparison of two therapy schedules for treatment of acute pelvic infection].
Fischbach F; Deckardt R; Graeff H
Geburtshilfe Frauenheilkd; 1994 Jun; 54(6):337-40. PubMed ID: 8088489
[TBL] [Abstract][Full Text] [Related]
22. Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycycline and metronidazole.
Heinonen PK; Leinonen M
Arch Gynecol Obstet; 2003 Oct; 268(4):284-8. PubMed ID: 14504870
[TBL] [Abstract][Full Text] [Related]
23. Multicenter comparison of cefotetan and cefoxitin in the treatment of acute obstetric and gynecologic infections.
Hemsell DL; Wendel GD; Gall SA; Newton ER; Gibbs RS; Knuppel RA; Lane TW; Sweet RL
Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):722-7. PubMed ID: 3281462
[TBL] [Abstract][Full Text] [Related]
24. Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients.
Arredondo JL; Diaz V; Gaitan H; Maradiegue E; Oyarzún E; Paz R; Reynal JL; Stamm W; Zambrano D
Clin Infect Dis; 1997 Feb; 24(2):170-8. PubMed ID: 9114143
[TBL] [Abstract][Full Text] [Related]
25. Outpatient parenteral antibiotic therapy. Management of serious infections, Part II: Amenable infections and models for delivery. Pelvic inflammatory disease.
Sweet RL
Hosp Pract (Off Ed); 1993 Jul; 28 Suppl 2():25-30; discussion 58-9. PubMed ID: 8325924
[TBL] [Abstract][Full Text] [Related]
26. Identification of novel microbes associated with pelvic inflammatory disease and infertility.
Haggerty CL; Totten PA; Tang G; Astete SG; Ferris MJ; Norori J; Bass DC; Martin DH; Taylor BD; Ness RB
Sex Transm Infect; 2016 Sep; 92(6):441-6. PubMed ID: 26825087
[TBL] [Abstract][Full Text] [Related]
27. A comparison of two antibiotic regimens for treatment of pelvic inflammatory disease.
Soper DE; Despres B
Obstet Gynecol; 1988 Jul; 72(1):7-12. PubMed ID: 3132668
[TBL] [Abstract][Full Text] [Related]
28. [The use of the antibiotic cefoxitin (Mefoxin) in gynecological practice].
Stoĭkov S; Popov I
Akush Ginekol (Sofiia); 1997; 36(3):57-9. PubMed ID: 9618966
[TBL] [Abstract][Full Text] [Related]
29. An audit of outpatient management of pelvic inflammatory disease.
Piyadigamage A; Wilson JD
Int J STD AIDS; 2002 Aug; 13(8):577-9. PubMed ID: 12194744
[TBL] [Abstract][Full Text] [Related]
30. Pelvic inflammatory disease in the adolescent: understanding diagnosis and treatment as a health care provider.
Woods JL; Scurlock AM; Hensel DJ
Pediatr Emerg Care; 2013 Jun; 29(6):720-5. PubMed ID: 23714759
[TBL] [Abstract][Full Text] [Related]
31. Pelvic inflammatory disease: guidelines for prevention and management.
MMWR Recomm Rep; 1991 Apr; 40(RR-5):1-25. PubMed ID: 2034205
[TBL] [Abstract][Full Text] [Related]
32. Pelvic inflammatory disease.
Brunham RC; Gottlieb SL; Paavonen J
N Engl J Med; 2015 May; 372(21):2039-48. PubMed ID: 25992748
[No Abstract] [Full Text] [Related]
33. A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis.
Wendel GD; Cox SM; Bawdon RE; Theriot SK; Heard MC; Nobles BJ
Am J Obstet Gynecol; 1991 May; 164(5 Pt 2):1390-6. PubMed ID: 2031520
[TBL] [Abstract][Full Text] [Related]
34. Recommendations and rationale for the treatment of pelvic inflammatory disease.
Jaiyeoba O; Lazenby G; Soper DE
Expert Rev Anti Infect Ther; 2011 Jan; 9(1):61-70. PubMed ID: 21171878
[TBL] [Abstract][Full Text] [Related]
35. Adverse adolescent reproductive health outcomes after pelvic inflammatory disease.
Trent M; Haggerty CL; Jennings JM; Lee S; Bass DC; Ness R
Arch Pediatr Adolesc Med; 2011 Jan; 165(1):49-54. PubMed ID: 21199980
[TBL] [Abstract][Full Text] [Related]
36. A Randomized Controlled Trial of Ceftriaxone and Doxycycline, With or Without Metronidazole, for the Treatment of Acute Pelvic Inflammatory Disease.
Wiesenfeld HC; Meyn LA; Darville T; Macio IS; Hillier SL
Clin Infect Dis; 2021 Apr; 72(7):1181-1189. PubMed ID: 32052831
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of alternative outpatient pelvic inflammatory disease treatment strategies.
Smith KJ; Ness RB; Wiesenfeld HC; Roberts MS
Sex Transm Dis; 2007 Dec; 34(12):960-6. PubMed ID: 18077847
[TBL] [Abstract][Full Text] [Related]
38. Cefotetan: comparative and noncomparative studies in obstetric and gynecologic infections.
Knuppel RA; O'Bryan D; Lake M
South Med J; 1988 Feb; 81(2):185-8. PubMed ID: 3422519
[TBL] [Abstract][Full Text] [Related]
39. A randomized controlled trial of coil removal prior to treatment of pelvic inflammatory disease.
Altunyurt S; Demir N; Posaci C
Eur J Obstet Gynecol Reprod Biol; 2003 Mar; 107(1):81-4. PubMed ID: 12593901
[TBL] [Abstract][Full Text] [Related]
40. Acute pelvic inflammatory disease.
Eschenbach DA
Urol Clin North Am; 1984 Feb; 11(1):65-81. PubMed ID: 6369707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
